Polypeptide compound for removing wrinkles in eyes and preparation method of polypeptide compound
A polypeptide complex and wrinkle-removing technology, applied in cosmetic preparations, preparations for skin care, medical preparations containing active ingredients, etc., can solve the problem of inability to fundamentally remove skin wrinkles and pigmentation, safety and sequela Unpredictable and unable to improve skin metabolism and other problems, to achieve the effect of improving blood microcirculation, solving eye wrinkles, and promoting skin collagen production
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2016-01-13
Abstract
Description
Technical field
[0001] The present invention relates to a polypeptide complex used for wrinkle removal of eyes and a preparation method thereof. The complex is mainly used for eye skin and has the effects of removing wrinkles and delaying aging. Background technique
[0002] The skin around the eyes is the thinnest part of all skins of the human body. It is only a quarter of the thickness of the facial skin. There is almost no distribution of sebaceous glands and sweat glands. Therefore, it has no natural moisturizing ability, and it is not easy to store water. It is easy to cause dryness and dehydration. Weeks skin is very easy to age. With age, the eye skin is prone to wrinkles, expression lines, crow's feet, loss of elasticity and firmness, and sagging.
[0003] At present, there are many anti-wrinkle products commonly used, and their effects and effects are very different. Most products usually cannot improve skin metabolism, promote skin blood circulation, increase skin nutri...
Examples
Embodiment 1
[0023] (a) Add 70% pure water according to the proportion, heat to 80°C, add 0.3% 1,2-hexanediol, stir to dissolve, and then divide into two equal parts, namely A phase and B phase;
[0024] (b) Keep the temperature of phase A at 50°C, stir and add 0.4% sodium hyaluronate, continue to stir to dissolve and mix uniformly, then add 4% glycerin, continue to stir and mix uniformly, as phase I;
[0025] (c) 0.02% acetyl hexapeptide-3, 0.01% palmitoyl pentapeptide-3, 0.025% palmitoyl tetrapeptide-7, 0.035% tripeptide, 0.1% acetyl tetrapeptide-5 and 0.08 % Dipeptide-2 was added to phase B, stirred to dissolve and mixed evenly, filtered with a filter membrane with a filter hole of 0.45 μm, and the filtrate obtained was phase II;
[0026] (d) Add phase II to phase I under agitation, rinse the container of phase II with the remaining proportion of pure water, and add the rinse to phase I, stir and mix evenly;
[0027] (e) Adjust the pH value of the mixed solution with 15 wt% arginine to 6.0-7.0,...
Embodiment 2
[0029] (a) Add 80% pure water according to the proportion, heat to 80°C, add 0.5% 1,2-hexanediol, stir to dissolve, and then divide into two equal parts, namely A phase and B phase;
[0030] (b) Keep the temperature of phase A at 60°C, stir and add 0.4% sodium hyaluronate, continue to stir to dissolve and mix uniformly, then add 5% glycerin, continue to stir and mix uniformly, as phase I;
[0031] (c) 0.025% acetyl hexapeptide-3, 0.007% palmitoyl pentapeptide-3, 0.035% palmitoyl tetrapeptide-7, 0.035% tripeptide, 0.1% acetyl tetrapeptide-5 and 0.1 % Dipeptide-2 was added to phase B, stirred to dissolve and mixed evenly, filtered with a filter membrane with a filter hole of 0.45 μm, and the filtrate obtained was phase II;
[0032] (d) Add phase II to phase I under agitation, rinse the container of phase II with the remaining proportion of pure water, and add the rinse to phase I, stir and mix evenly;
[0033] (e) Adjust the pH of the mixed solution to 6.0-7.0 with 15 wt% arginine, and ...
Embodiment 3
[0035] (a) Add 80% pure water according to the proportion, heat to 80°C, add 0.4% 1,2-hexanediol, stir to dissolve, and then divide into two equal parts, namely A phase and B phase;
[0036] (b) Keep the temperature of phase A at 70°C, stir and add 0.2% sodium hyaluronate, continue to stir to dissolve and mix evenly, then add 6% glycerin, continue to stir and mix evenly, as phase I;
[0037] (c) 0.03% acetyl hexapeptide-3, 0.001% palmitoyl pentapeptide-3, 0.03% palmitoyl pentapeptide-7, 0.03% tripeptide, 0.15% acetyl tetrapeptide-5 and 0.12 % Dipeptide-2 was added to phase B, stirred to dissolve and mixed evenly, filtered with a filter membrane with a filter hole of 0.45 μm, and the filtrate obtained was phase II;
[0038] (d) Add phase II to phase I under agitation, rinse the container of phase II with the remaining proportion of pure water, and add the rinse to phase I, stir and mix evenly;
[0039] (e) Adjust the pH value of the mixed solution with 15 wt% arginine to 6.0-7.0, and t...